Lor You-Chen, Shih Pei-Ching, Chen Hsin-Hao, Liu Shu-Jung, Chao Hsingchu-Chu, Hwang Lee-Ching, Hsu Yen-Fen, Yeh Tzu-Lin
Department of Family Medicine, Hsinchu MacKay Memorial Hospital, Hsinchu City Medical Library, Tamsui MacKay Memorial Hospital, New Taipei City Department of Pediatrics Department of Family Medicine, Taipei MacKay Memorial Hospital, Taipei City MacKay Medical College, New Taipei City Department of Nursing, Hsinchu MacKay Memorial Hospital, Hsinchu City, Taiwan.
Medicine (Baltimore). 2018 Feb;97(5):e9746. doi: 10.1097/MD.0000000000009746.
Nasogastric (NG) tube insertion is a common procedure in the clinical setting that causes much discomfort and pain for the patient. Pain control is often suboptimal, as many NG tube insertions are performed without any pain-relieving supplements. The aim of this study was to summarize and critically evaluate the evidence from randomized controlled trials (RCTs) on the effect and adverse effects of lidocaine agents in reducing pain and discomfort associated with NG tube insertion.
Databases from the Cochrane Library, MEDLINE, EMBASE, Airiti Library, PerioPath Index to Taiwan Periodical Literature, and Cumulative Index of Nursing and Allied Health (CINAHL) were searched from inception to April 2017. RCTs focusing on lidocaine before NG tube insertion were appraised. The primary outcome was the visual analog scale (VAS) score. The modified Jadad scale was used for quality assessment. Mean difference (MD) with 95% confidence intervals (95% CIs) and odds ratio (OR) for binary outcomes were assessed by a random effects model. Heterogeneity was determined by using the Cochran Q test and I statistics. Publication bias was analyzed by using a funnel plot analysis.
Ten RCTs enrolling 734 patients were included in the meta-analysis. Eight of the 10 RCTs reporting VAS scores had sufficient quantitative data to be pooled through meta-analysis. Results revealed a significant reduction in VAS score, with a MD of -26.05 and a CI of -28.21 to -23.89 with moderate heterogeneity (P < .001, I = 56%). There were no significant changes in difficulty of NG tube insertions (MD = -0.30, 95% CI, -1.30 to 0.70, P = .55), number of NG tube insertion attempts (MD = -0.22, 95% CI, -0.98 to 0.53, P = .56), nasal bleeding (OR = 0.62, 95% CI, 0.11-3.41, P = .59), and vomiting (OR = 0.30, 95% CI, 0.07-1.27, P = .10).
This meta-analysis suggests that applying lidocaine before NG tube insertion can alleviate pain and discomfort by 26% without increasing nasal bleeding or vomiting.
鼻胃管插入术是临床常见操作,会给患者带来诸多不适与疼痛。由于许多鼻胃管插入操作未使用任何止痛辅助措施,疼痛控制往往欠佳。本研究旨在总结并严格评估来自随机对照试验(RCT)的证据,以探讨利多卡因制剂在减轻鼻胃管插入相关疼痛和不适方面的效果及不良反应。
检索Cochrane图书馆、MEDLINE、EMBASE、华艺数位图书馆、台湾期刊文献牙周病索引以及护理及相关健康累积索引(CINAHL)数据库,检索时间从建库至2017年4月。对聚焦于鼻胃管插入术前使用利多卡因的随机对照试验进行评估。主要结局指标为视觉模拟量表(VAS)评分。采用改良Jadad量表进行质量评估。通过随机效应模型评估二元结局的平均差(MD)及95%置信区间(95%CI)和比值比(OR)。使用Cochran Q检验和I统计量确定异质性。通过漏斗图分析评估发表偏倚。
10项纳入734例患者的随机对照试验被纳入荟萃分析。10项报告VAS评分的随机对照试验中有8项具有足够的定量数据可通过荟萃分析进行汇总。结果显示VAS评分显著降低,MD为-26.05,CI为-28.21至-23.89,异质性中等(P<0.001,I=56%)。鼻胃管插入难度(MD=-0.30,95%CI,-1.30至0.70,P=0.55)、鼻胃管插入尝试次数(MD=-0.22,95%CI,-0.98至0.53,P=0.56)、鼻出血(OR=0.62,95%CI,0.11 - 3.41,P=0.59)及呕吐(OR=0.30,95%CI,0.07 - 1.27,P=0.10)均无显著变化。
本荟萃分析表明,在鼻胃管插入术前应用利多卡因可减轻26%的疼痛和不适,且不会增加鼻出血或呕吐的发生。